P/E ratio for Fortis Healthcare (FORTIS.NS)
P/E ratio as of September 2023 (TTM): 42.7
According to Fortis Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.6673. At the end of 2022 the company had a P/E ratio of 38.1.
P/E ratio history for Fortis Healthcare from 2012 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 38.1 | -127.57% |
| 2021 | -138 | -183.81% |
| 2020 | 165 | -547.1% |
| 2019 | -36.9 | 460.63% |
| 2018 | -6.59 | -132.36% |
| 2017 | 20.3 | -106.2% |
| 2016 | -328 | 511.49% |
| 2015 | -53.6 | -248.75% |
| 2014 | 36.1 | 350.79% |
| 2013 | 8.00 | -85.79% |
| 2012 | 56.3 | 20.33% |
| 2011 | 46.8 | -32.6% |
| 2010 | 69.4 | -3.18% |
| 2009 | 71.7 | -321.73% |
| 2008 | -32.3 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.